Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.4B |
| Enterprise Value | 2.2B |
| P/E Ratio | 12.17 |
| PEG Ratio | -1.98 |
| Price/Sales Ratio | 4.1 |
| Price/Book Ratio | 1.61 |
| Enterprise/Revenue | 3.82 |
| Enterprise/EBITDA | 10.73 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.23 |
| Operating Margin | 0.27 |
AD
Management Effectiveness
| Return On Assets | 0.11 |
| Return On Equity | 0.14 |
Income Statement
| Revenue | 812.35M |
| Revenue/Share | 2.62 |
| Gross Profit | 567.01M |
| EBITDA | 322.38M |
| Net Income | 195.12M |
| Diluted EPS | 0.61 |
Balance Sheet
| Total Cash | 268.78M |
| Total Cash/Share | 0.85 |
| Total Debt | 38.01M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 1.74 |
| Book Value Per Share | 4.61 |
Price History
| 52-Week Change | -28.29 |
| 52-Week High | 10.97 |
| 52-Week Low | 6.83 |
| Moving Average 50 Days | 7.45 |
| Moving Average 200 Days | 7.98 |
Statistics
| Average Volume | 6.44M |
| Shares Outstanding | 458.23M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.3 |
| Trailing Annual Dividend Yield | 4.05 |
| Payout Ratio | 0.42 |
| Last Split Factor | 7:5 |
| Last Split Date | June 26, 2026 |
AD
